Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

Front Pharmacol. 2021 Feb 8:11:637775. doi: 10.3389/fphar.2020.637775. eCollection 2020.

¹ National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
² Independent Medical Consultant, and Consultant, Pharmaceutical Medicine, Athens, Greece.
³ Consultants in Pharmaceutical Medicine, Dover Heights, Australia.
⁴ LIF, Stockholm, Sweden.
⁵ Independent Consultant, Basel, Switzerland.
⁶ Independent Researcher, Bellagio, Italy.
⁷ Pfizer Biopharmaceuticals Group, Dublin, Ireland.
⁸ Craveri Pharma, Buenos Aires, Argentina.
⁹ Cantonal Ethics Committee, Zurich, Switzerland.
¹⁰ Eli Lilly & Co., Lisbon, Portugal.
¹¹ Nippon Medical School, Tokyo, Japan.
¹² Ferozsons Laboratories Ltd, Karachi, Pakistan.
¹³ PPH Plus GmbH & Co. KG, Hochheim am Main, Germany.
¹⁴ IFAPP Academy, New York, NY, United States.
¹⁵ Semmelweis University, Budapest, Hunbary.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.579714.].

Keywords: data science; data sharing; declaration of Helsinki; declaration of Taipei; medicines development; privacy protection; research ethics.